A unique property of many adult stem cells is their ability to exist in a non-cycling, quiescent state 1 . Although quiescence serves an essential role in preserving stem cell function until the stem cell is needed in tissue homeostasis or repair, defects in quiescence can lead to an impairment in tissue function 2 . The extent to which stem cells can regulate quiescence is unknown. Here we show that the stem cell quiescent state is composed of two distinct functional phases, G 0 and an 'alert' phase we term G Alert . Stem cells actively and reversibly transition between these phases in response to injury-induced systemic signals. Using genetic mouse models specific to muscle stem cells (or satellite cells), we show that mTORC1 activity is necessary and sufficient for the transition of satellite cells from G 0 into G Alert and that signalling through the HGF receptor cMet is also necessary. We also identify G 0 -to-G Alert transitions in several populations of quiescent stem cells. Quiescent stem cells that transition into G Alert possess enhanced tissue regenerative function. We propose that the transition of quiescent stem cells into G Alert functions as an 'alerting' mechanism, an adaptive response that positions stem cells to respond rapidly under conditions of injury and stress, priming them for cell cycle entry.
Adult stem cells have been presumed to exist in one of two states: (1) the quiescent state in which the cell is not actively cycling and (2) the activated state where the cell has committed to or is in the cell cycle 3, 4 . In contrast to the cell cycle, which can be sub-divided into distinct phases, quiescence is not as well characterized. Emerging data suggest that stem cells can regulate quiescent functional properties 5, 6 . Studying the regulation of the transition of satellite cells (SCs) from the quiescent to the activated state, we made a curious observation-SCs in a muscle contralateral to the muscle in which we induced an injury (contralateral satellite cells, CSCs) responded to that distant injury and had cycling properties that were different from those in a non-injured animal (quiescent satellite cells, QSCs) and from the injured tissue (activated satellite cells, ASCs) ( Fig. 1a ). Using the Pax7 CreER driver and Rosa26 EYFP lineage tracer to specifically label SCs 7, 8 (Extended Data Fig. 1a ), we found that these CSCs showed markedly increased, but overall still low, propensity to cycle when compared to QSCs, as measured by BrdU (5-bromodeoxyuridine) incorporation in vivo (Fig. 1b) . Upon isolation and culturing ex vivo, CSCs displayed accelerated cell cycle entry as measured by EdU incorporation and time required to complete the first cell division compared to QSCs (Fig. 1c, d) . Subsequent cell divisions of progeny of CSCs and QSCs occurred at similar rates to those of ASCs (Extended Data Fig. 1b ). This functional response was not limited to SCs in muscle groups directly contralateral to the injury or to the agent of muscle injury (Extended Data Fig. 1c-e ).
One of the most obvious changes in ASCs is a dramatic increase in cell size relative to QSCs (Fig. 2a ). We found that CSCs displayed a very slight, but significant, increase in cell size relative to QSCs (Fig. 2a, b and Extended Data Fig. 2a, b) . Similarly, we also observed that CSCs had stronger EYFP intensity from the Rosa26 EYFP reporter, elevated levels of pyronin Y staining, and increased incorporation of the ribonucleotide EU compared to QSCs (Extended Data Fig. 2c-e ), which suggests increased transcriptional activity. Principle component analysis (PCA) of the transcriptional profiles of QSCs, CSCS and ASCs showed that CSCs fall between QSCs and ASCs along the first component axis (PC1) (Fig. 2c ). Transcriptionally, CSCs were highly correlated with both QSCs and ASCs, more strongly than QSCs and ASCs were correlated (Fig. 2c ), which also 1 suggests that CSCs are intermediate between QSCs and ASCs. However, detailed immunocytochemistry analysis immediately after isolation showed that CSCs are phenotypically more similar to QSCs (Extended Data Fig. 2f -i). To test if CSCs represent a population of stem cells or a population of committed progenitor cells, we performed transplantation and pulse-chase experiments and found no difference in the engraftment efficiency and capacity for self-renewal between CSCs and QSCs (Extended Data Fig. 2j , k). Together, these data suggest that CSCs are similar to, but distinct from, QSCs and possess the stem cell characteristics of QSCs.
To gain further insight into what distinguishes CSCs from QSCs, we analysed the molecular pathways enriched in genes induced in the CSC transcriptome relative to the QSC expression profile. We found that two annotation groups were significantly enriched in genes upregulated in CSCs relative to QSCs: cell cycle and mitochondrial metabolism (Extended Data Fig. 3a ). To further investigate mitochondrial metabolism in CSCs, we performed MitoTracker Deep Red staining and measured mtDNA content and found that, relative to QSCs, CSCs displayed evidence of elevated mitochondrial activity ( Fig. 2d, e ). Consistent with these findings, and keeping with the increase in cell size, we also found that CSCs have increased levels of cellular ATP ( Fig. 2f and Extended Data Fig. 3b-d ).
Collectively these data describe a set of properties that distinguishes CSCs from QSCs and ASCs: kinetics of cell cycle entry, propensity to cycle, cell size, transcriptional activity and mitochondrial metabolism. Importantly, CSCs, like QSCs, are still quiescent in that, as a population, almost all CSCs are not actively cycling. Because the injury-induced phenotype of CSCs is intermediate between QSCs and ASCs, we refer to CSCs as 'alert' SCs and the set of properties that distinguishes these cells as the 'alert' phenotype. The characteristics of this alert phenotype described above have a common thread in that they have all been previously linked, in other systems, to the mTORC1 signalling pathway (reviewed in ref. 9). For example, we observed induction of phospho-S6 (pS6), a surrogate of mTORC1 activity, in alert SCs (Fig. 2g , h and Extended Data Fig. 3e-g ). Furthermore, we found that by sorting SCs for properties of the alert state (Extended Data Fig. 3h ), we enriched for a population of pS6 1 SCs that also possessed the other attributes of the alert state (elevated propensity to cycle and reduced time to first division) (Extended Data Fig. 3i -m). Together these data show that there is a strong correlation between activation of mTORC1 signalling and the alert phenotype in SCs.
To test if any aspects of the alert response were directly regulated by mTORC1 signalling, we used the Pax7 CreER driver to specifically ablate TSC1, an inhibitor of mTORC1 signalling, in SCs. As a genetic model of mTORC1 activation 10 , TSC1 knockout (KO) QSCs displayed induction of mTORC1 activity (Extended Data Fig. 4a, b ). TSC1 KO QSCs also displayed all aspects of the alert phenotype in an otherwise noninjury context: increased propensity to cycle, accelerated cell cycle entry, increased MitoTracker Deep Red staining and increased cell size ( Fig. 3a -c and Extended Data Fig. 4c ). To test whether the alert response requires mTORC1, we used a conditional allele of Raptor (Rptor) 11 , an essential component of the mTORC1 signalling complex, with the Pax7 CreER driver to specifically ablate Rptor expression and suppress mTORC1 signalling in SCs (Extended Data Figs 4b and 5a-c). Overall, we found that Rptor KO SCs contralateral to a muscle injury were completely unresponsive to the injury and did not manifest any of the injury-induced 
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changes that alert wild-type CSCs display ( Fig. 3d-f and Extended Data Fig 5d, e ). These data combined show that mTORC1 signalling in SCs is necessary and sufficient for the alert response. Next, we focused on the signals upstream of mTORC1 which initiate the alert response and which are regulated by injury. Latent hepatocyte growth factor (HGF) is found in the extracellular matrix of many tissues; upon injury it is processed into an active form by serum proteases 12, 13 . Active HGF can regulate mTORC1 via PI3K-Akt signalling 14 . Furthermore HGF is known to influence SC behaviour 15, 16 . To test if HGF signalling has a role in the alert response, we used conditional ablation of the HGF receptor, cMet, to suppress HGF signalling in SCs 17 . Ablation of cMet in SCs completely blocked the activation of mTORC1 signalling, as measured by pS6 staining, in cultured SCs and in vivo in CSCs following injury (Extended Data Figs 4b and 5f, g). Consistent with our hypothesis that mTORC1 activation is required for the alert response in SCs, cMet KO CSCs did not exhibit any functional response to injury ( Fig. 3g -i and Extended Data Fig. 5h ). Collectively, these data suggest that signalling downstream of cMet is critical for the induction of the alert response in SCs.
Following tissue repair after injury, activity of the HGF activation cascade gradually subsides 12 . We found the frequency of pS6 1 CSCs following a distant injury declined to a level similar to that of non-injured animals 28 days post-injury (DPI) (Extended Data Fig. 6a ). We also found that at 28 DPI the propensity to cycle and cell cycle entry kinetics of CSCs returned to those of QSCs (Extended Data Fig. 6b , c). Furthermore, the transcriptional profile of CSCs 28 DPI had returned to that of QSCs (Extended Data Fig. 6d ). These data indicate that the alert state is reversible and that the functional and transcriptional changes in alert CSCs that occur downstream of mTORC1 revert to the properties of QSCs when mTORC1 activity subsides.
To gain further understanding of the molecular pathways underlying the functional transition into the alert state, we analysed the transcriptional profiles from the SC-specific genetic models described above. We found that induction of genes involved in mitochondrial metabolism strongly correlated with the ability to transition into the alert state.
Wild-type CSCs and TSC1 KO QSCs show induction and Rptor KO and cMet KO CSCs do not (Extended Data Figs 3a and 7a-e
). These data suggest that regulation of mitochondrial metabolism is a crucial aspect of stem cell quiescence.
The function of SCs in response to injury is to proliferate, differentiate and form new muscle tissue 18, 19 . As such, we tested whether the functional changes of CSCs affected their differentiation and muscle regenerative abilities. Following isolation and ex vivo culturing, CSCs displayed enhanced kinetics of differentiation as measured by expression of myogenin (MyoG) and cell fusion (Fig. 4a, b and Extended Data Fig. 8a ). To translate these observations in vivo, we assessed the ability of CSCs to participate in muscle regeneration. Three days before injury of the left tibialis anterior (TA) muscle, we performed an 'alerting' injury to the right limb to transition SCs in the left TA into the alert state ( Fig. 4c ). We found that animals that received an 'alerting' injury displayed strikingly enhanced muscle regeneration at all time points following injury when compared to the normal muscle regenerative process ( Fig. 4d, e ). These data show that the functional properties of alert SCs translate into enhanced muscle regenerative ability in response to injury.
The markedly enhanced muscle regenerative function of CSCs prompted us to investigate other conditions which may induce the alert state in SCs. We found that SCs adopted functional aspects of the alert response to bone injuries and to minor skin wounds (Extended Data Fig. 8b, c) , injuries for which the role of SCs is not apparent. These data suggest that SCs can adopt the alert state in response to multiple types of injuries and may be a general response of SCs to injury. Therefore, we tested if other populations of quiescent stem cells could similarly adopt properties of the alert state. We found that fibro-adipogenic progenitors (FAPs), a resident mesenchymal stem cell population in skeletal muscle 20, 21 , responded in a similar way as SCs. CFAPs (FAPs in muscles of a limb contralateral to the site of muscle injury) displayed an induction of mTORC1 signalling, accelerated cell cycle entry, increased propensity to cycle and increased cell size when compared to quiescent FAPs from non-injured animals (QFAPs) ( 
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activation of mTORC1 signalling in response to muscle injury ( Fig. 4i and Extended Data Fig. 9d ). To test if mTORC1 activation in LT-HSCs caused increased functional potential, as it does in SCs, we then administered interferon-gamma (IFN-c), to the animals to stimulate LT-HSC activation 22 . Similar to the effect of an 'alerting' injury on muscle regeneration, LT-HSCs primed by muscle injury were more sensitive to IFN-c and had a more robust response (Fig. 4j) . Notably, and similar to what we demonstrated in SCs, the induction of mTORC1 in HSCs increases their mitochondrial activity 23, 24 , which is consistent with a transition into the alert state. Collectively, these data indicate that activation of mTORC1 signalling in quiescent stem cells alters their properties, endowing them with enhanced functional potential, an alerting mechanism that prepares the cell for potential activation.
As it relates to stem cell biology, the data we present here demonstrate that stem cells undergo dynamic transitions between functional phases in the quiescent state. We propose a model in which G Alert and G 0 are phases within quiescence and form a quiescence cycle (Fig. 4k) . Although it has been suggested that not all quiescent cells are functionally equivalent 25, 26 , the in vivo relevance and the molecular mechanisms regulating functionally distinct states had not previously been elucidated. We propose that mTORC1 activity is a distinguishing aspect of at least two distinct phases within quiescence. Here we demonstrate how these phases of stem cell quiescence in vivo are regulated in the context of physiological conditions by mTORC1 (and, for SCs, by cMet). Most importantly, our data indicate that the ability to transition between G 0 and G Alert is critical to the positioning of stem cell populations to be able to respond rapidly in tissue homeostasis and repair while maintaining a pool of deeply quiescent, reserve stem cells. This represents a newly identified form of cellular memory, an adaptive response akin to that in neuronal or immune cells, in which prior experience influences future responses.
METHODS SUMMARY
Unless stated otherwise, in the figure legend, all graphical data are presented as mean 6 s.e.m., except for histograms, and significance was calculated using twotailed unpaired Student's t-tests: *P , 0.05, **P , 0.01. When sample size (n values) are reported as a range, exact sample size values can be found in the Methods section. Time to first division experiments are presented as a representative histogram plotting data from individual cells and, on the right, as a bar graph depicting the quantitative analysis of the mean time to first division in replicate experiments.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Mice. TSC1 fl , Raptor fl , cMet fl , Rosa26 EYFP and NSG mice were obtained from the Jackson Laboratory. Pax7 CreER mice were provided by Dr. Charles Keller (OHSU). All experiments were performed with 12-16-week-old male C57BL/6 mice, except in experiments with conditional cMet KO, and associated controls, which were in a mixed background of C57BL/6 and FVB. Animals were genotyped by PCR of tail DNA, except in Extended Data Fig. 5c which was performed using isolated SCs and FAPs, primer sequences available upon request. The genotypes of experimental KO and associated control animals are as follows: TSC1 KO (TSC1 fl/fl ;Pax7 CreER/1 ; Rosa26 EYFP/1 ) andwildtype(TSC1 1/1 ;Pax7 CreER/1 ;Rosa26 EYFP/1 ), Rptor KO (Rptor fl/fl ; Pax7 CreER/1 ;Rosa26 EYFP/1 ) and wild type (Rptor 1/1 ;Pax7 CreER/1 ;Rosa26 EYFP/1 ), cMet KO (cMet fl/fl ;Pax7 CreER/1 ;Rosa26 EYFP/1 ) and WT (cMet 1/1 ;Pax7 CreER/1 ;Rosa26 EYFP/1 ). Tamoxifen (TMX) (Sigma) was prepared in a mixture of corn oil and 7% ethanol and administered in 5 doses of 50 mg every 2-3 days by intraperitoneal (i.p.) injection. TMX injections were initiated on 6-8-week-old mice, and experimental mice were used 2-4 weeks after TMX administration. In pulse labelling experiments, 10 mg of BrdU were injected i.p. 12 h before mice were euthanized. In continuous labelling experiments, BrdU (0.8 mg ml 21 ) was administered in the drinking water with 1% sucrose for the indicated period. Mice were housed and maintained in the Veterinary Medical Unit at Veterans Affairs Palo Alto Health Care Systems. Animal protocols were approved by the Administrative Panel on Laboratory Animal Care of VA Palo Alto Health Care System. Injury models. BaCl 2 was used as the agent for muscle injury unless stated otherwise. Briefly, mice were anaesthetized with isoflurane, and the lower hindlimb was shaved and skin was sterilized. A total of 70 ml of 1.2% BaCl 2 (w/v H 2 O) was injected into and along the length of the tibialis anterior (TA) and gastrocnemius (Gas) muscles. Mice were given analgesic and antibiotics and allowed to recover. Muscle crush injuries were performed by opening the skin and fascia over the TA muscle, injuring the muscle with a hemostat along the length of the TA, and closing the skin with sutures. Skin injuries were performed by using scissors to make a 2 cm incision on the abdomen without injuring the peritoneum and closing the incision with wound clips. In all experiments, control, non-injured animals were subject to a mock injury: animals were anaesthized and administered analgesic and antibiotics. Muscle regeneration. Alert regeneration experiments were performed as depicted in Fig. 4c , by injuring the TA and Gas muscle in the right hindlimb on day 23 followed by injuring the TA muscle in the left hindlimb on day 0. Control, normal regeneration animals were anaesthetized and given antibiotics and analgesics on day 23. On day 0, normal regeneration animals were subject to identical injuries as alert regeneration animals. At indicated DPI, animals were euthanized, the left TAs extracted, and prepared for histological analysis by freezing in liquid nitrogen cooled isopentane. TA muscles extracted 3.5 and 5 DPI were sectioned and subject to IF-IHC staining with eMHC and laminin antibodies to identify nascent muscle fibres. TA muscles extracted 11, 15, and 24 DPI were sectioned and subject to haematoxylin and eosin (H&E) staining to identify centrally nucleated fibres. The crosssectional area (CSA) was of nascent fibres in posterior portion of the TA muscle approximately halfway along the proximal-distal axis was performed using AxioVision software (Zeiss). Cell isolation and FACs purification. Satellite cell isolation was performed as previously described 6 . Briefly, following death, hindlimb skeletal muscles were removed, minced and digested in collagenase and dispase. Satellite cells were purified by gating mononuclear EYFP 1 cells using a BD FACSAria II or III. As depicted in Fig. 1a , QSCs were isolated from TA and Gas muscle of non-injured animals, ASCs were isolated from injured TA and Gast muscles, and CSCs isolated from TA and Gast contralateral to the injury.
FAPs were purified from muscles isolated and digested as in the SC isolation protocol. Following digestion, FAPs were stained and purified as a population of CD31 2 /CD45 2 and Sca-1 1 mononuclear cells, using the following antibodies: CD31-APC (clone MEC 13.3; BD Bioscience), CD45-APC (clone 30-F11; BD Bioscience), Sca1 PacBlue (clone D7; BioLegend).
All FACS comparisons (size, MitoTracker, EYFP, EU, pS6) are from isolations performed on the same day and analysed on the same FACS instrument (BD FACSAria II or III). All FACS plots are representative experiments with similar results in at least 3 independent experiments. Analysis of HSCs. For mTOR analysis, lin -(lineage markers: B220, CD4, CD8, CD11b, Ly6G, Ter119) cKit 1 Sca1 1 CD150 1 cells were obtained from bone marrow 24 h after injury or mock injury and stained with phospho-mTOR or phospho-S6 antibodies.
For IFN-c experiments, animals were subjected to muscle injury or mock injury as described above. After 24 h, HSC division was induced with IFN-c (100 ng per mouse) or PBS by intravenous injection, and 4 mg BrdU was injected i.p. After an additional 24 h, the mice were euthanized and BrdU incorporation was measured in HSCs (Lin 2 Sca 1 cKit 1 CD150 1 CD48 2 EPCR 1 ) (BrdU FlowKit; BD Bioscience).
Satellite cell transplantation. Donor EYFP 1 SCs were FACS purified from Pax7 CreER/1 ; Rosa26 EYFP/1 mice, 2.5 DPI (CSCs) or from non-injured animals (QSCs). Donor SCs were counted, washed with PBS and resuspended in PBS with 0.1% BSA at a concentration of 5 3 10 4 cells in 20 ml. The TA muscle of the host, 12-week-old male NSG mice, was prepared by BaCl 2 injury two days before transplantation. The transplantation was performed by anaesthetizing the host mice, exposing the TA muscle by opening the skin and fascia, and slowly injecting 20 ml of the donor cell solution into the TA using a 50 ml Hamilton syringe. Each host mouse received transplantation of QSCs into the right TA and CSCs into the left TA. After injection, the skin over the TA was closed by sutures, the mice were administered analgesic and antibiotics and were allowed to recover. Two weeks after transplantation, SC engraftment was measured by FACS of EYFP 1 SCs from the TA muscle of donor mice. Mitotracker staining. Prior to FACs analysis, 200 nM MitoTracker Deep Red (Invitrogen) was added to muscle digests and incubated for 1 h at 37 uC, with gentle shaking. Digests were washed once and MitoTracker staining was visualized on a BD FACSAria II or III in the APC channel. Cell culture. SCs and FAPs were cultured on ECM (Sigma) coated poly-D-lysine 8-well chamber slides (BD), 15,000 cells were plated per well and cultured overnight in Hams F10 medium (Cellgro) with 10% fetal bovine serum (Gibco), the next day the medium was switched to Hams F10 with 10% horse serum (Gibco), and cells were cultured in this medium until fixation by PFA. In EdU incorporation experiments, 0.05 mM EdU (Invitrogen) was added to the culture medium and replenished every 12 h until cells were fixed. SCs were fixed 40 h after plating and FAPs were fixed 48 h after plating. For in vivo BrdU pulse labelling experiments, cells were isolated, plated and fixed 2 h after isolation. Time-lapse microscopy. To perform time-lapse microscopy analysis, 10,000 SCs were plated onto ECM coated 8-well chamber slides and allowed to adhere for several hours to slides. After the cells adhered the medium was changed to Hams F10 with 10% HS and the slides were transferred to an environmentally controlled Zeiss Axiophot 200M equipped Axiocam. Time-lapse data acquisition and visualization was made using AxioVision software and images were captured every 15 min. The time required to complete the first division after plating was recorded only for cells that stayed within the acquisition field. Representative data from time-lapse experiments are displayed as histograms, bar graphs of time to first division display quantification of replicate experiments (mean 6 s.e.m.). ATP measurement. SC ATP levels were measured using the ATP Bioluminescence Assay Kit CLS II (Roche) according to the manufacturer's instructions. Briefly, 20,000 SCs were counted with a haemocytometer immediately after isolation, pelleted, and boiled in 100 mM Tris, 4 mM EDTA, pH 7.4 for 2 min. After boiling, the debris was pelleted and supernatant was used for analysis. Immunostaining. Immunofluorescence immunohistochemistry (IF-IHC) was performed on muscle tissue that was mounted with tragacanth gum and snap frozen in isopentane cooled in liquid nitrogen immediately after dissection. The 8-mm sections were fixed in 4% PFA for 5 min and blocked in donkey serum before staining. Pax7 and eMHC staining was performed with the M.O.M. kit (Vector) according to the manufacturer's instructions. pS6 staining was performed following Pax7 staining by incubating the sections in a solution of PBS, 0.3% Triton X-100, 10% donkey serum and rabbit anti-pS6 antibodies at a dilution of 1:100, overnight. Secondary detection of pS6 was performed with donkey anti-rabbit Alexa 647 antibodies (Invitrogen) at a dilution of 1:500.
Immunocytochemistry (ICC) staining was performed on PFA fixed cells that had been cultured on chamber slides. EdU incorporation was visualized by Click-iT (Invitrogen) according to the manufacturer's instructions. For BrdU analysis, cells were fixed with 70% ethanol and treated with 2N HCl for 20 min before staining with BrdU antibodies. Image capture, analysis and quantification were performed using Volocity software.
All displayed immunostaining images are representative of at least 3 independent experiments. Western blotting. Western blot analysis was performed on whole cell extracts of 1 3 10 5 SCs that were counted, washed and lysed in sample buffer immediately after FACS purification. Lysates were subject to SDS-PAGE, transferred to PVDF membrane, and probed with indicated antibodies. Between antibody probing, the PVDF membrane was stripped using Restore Western Blotting Stripping Solution (Pierce). Bioluminescence. Photo-emission was measured using 10,000 (CD31 2 , CD45 2 , Sca-1 2 , VCAM 1 ) SCs purified by FACS from non-injured or 2.5 DPI Pax7 CreER/1 ; Rosa26 LuSeAP/1 mice. SCs were allowed to adhere to ECM-coated 6-well plates for 1 h before addition of luminal and imaging with an IVIS imager. mtDNA quantification. Total DNA was isolated from 10,000 SCs immediately after FACS isolation using QIAamp DNA micro kit (Qiagen) according to the manufacturer's instructions. mtDNA was quantified by qRT-PCR using primers amplifying the Cytochrome B region on mtDNA (forward primer: 59-CATTTAT
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TATCGCGGCCCTA-39, reverse primer: 59-TGTTGGGTTGTTTGATCCTG-39) relative to the b-globin region on gDNA (forward primer: 59-GAAGCGATTCTA GGGAGCAG-39, reverse primer: 59-GGAGCAGCGATTCTGAGTAGA-39). Cell size measurements FACS. Throughout the dissection, digestion, and processing of muscle tissue (described above), preparations were maintained at 37 uC. Immediately upon completion of the isolation protocol, mononuclear EYFP 1 cells were analysed in the forward scatter channel (FSC) by FACS to assess cell size. Data are presented as representative histograms. Microscopy. Immediately after isolation, QSCs, 2.5 DPI CSCs, and 2.5 DPI ASCs were plated on 8-well chamber slides and allowed to adhere for 30 min at 37 uC, after which the media was aspirated, chambers removed and a coverslip applied. Bright field images of the slides were acquired using an Axioskop 2 with a 340 objective lens. The analysis of cell diameter was performed using AxioVision software (Zeiss). Antibodies. Antibodies used in this study were: anti-Pax7 (#pax7) and anti-eMHC (#F1.652) from DSHB; phospho-S235/6 S6 (#4858 and #4857) and phospho-S2448 mTOR (#2971) from Cell Signaling; rabbit anti-GFP (#A11122) from Invitrogen; chicken anti-GFP (#ab15580), rat anti-laminin (#ab11576) and anti-Raptor (#ab40768) from AbCam; anti-PDGFRa (#AF1062) from R&D Systems; anti-Myogenin (#566358) and anti-MyoD (#554130) from BD; anti-BrdU (#OBD0030G) from Serotec; actin (#A3854) from Sigma. For HSCs: lineage antibodies: anti-B220 (#515-0452-82), anti-CD4 (#515-0042-82), anti-CD8 (#515-0081-82), anti-Mac1 (#515-0112-82), anti-Gr1 (#15-5931-82), anti-Ter119 (#515-5921-82); anti-Ly6A (Sca1) (#25-5981-81); anti-CD117 (cKit) (#747-1171-82), anti-CD150 (#12-1502-82), anti-CD48 (#17-0481-82), anti-EPCR (#17-2012-80) from eBiosciences. Transcriptional profiling and pre-processing. For each sample, total RNA was isolated by TRIzol (Invitrogen) extraction followed by RNeasy Plus Micro Kit (Qiagen) from ,400,000 SCs pooled from $ 4 mice. Hybridization to GeneChip Mouse Gene 1.0 ST Affymetrix arrays was performed by the Stanford Protein and Nucleic Acid Facility. Raw data files are available at the NCBI GEO database (accession numbers GSE55490 and GSE47177).
Intensities were pre-processed using the Expression Console (Affymetrix) for RMA, and probe-sets that cross-hybridized, mapped to multiple transcripts or showed poor signal (intensity of ,6.5) in all arrays were excluded. Processed array data are available as Supplementary Data Set 1. Arrays were batch-corrected using ComBat 28 , and technical replicates were averaged. Probe sets lacking gene symbol annotation were excluded, and for transcripts covered by multiple probe sets, the most informative probe set with average intensity in the top two-thirds of sets for a transcript was selected 29,30 . Transcriptional profile analysis. All analyses were performed on mean-centred log 2 -transformed expression levels.
For gene annotation analysis, the background gene set was all genes after preprocessing (15,343 genes) . For each comparison between conditions, to ensure biological importance and reproducibility, the foreground gene set was selected as the smallest of the following: the gene set with 10% FDR by rank products analysis 31,32 , all genes with at least 1.5-fold directional change between conditions, or the top 1,100 genes ranked by directional fold change. Enrichment analysis and redundancy grouping of KEGG pathways 33 was performed using GeneTerm Linker 34 with corrected P value ,0.05, minimum genes per term 4 and minimum silhouette 0.5.
K-medians clustering with the k-means11 seeding algorithm and Manhattan distance was performed on KEGG pathway oxidative phosphorylation genes (ID mmu00190) with k 5 3. The partition with the smallest sum of intracluster distances was chosen. This partition was validated as being the most tightly clustered (best average sample shadow (0.38) and silhouette (0.61)), robust against different seeds (highest frequency as optimal partition (0.47)), and robust against noise (highest average frequency of reproduced cluster pairs during random projections to lower dimensions (0.80)) 35 . Statistics. Unless stated otherwise, significance was calculated using two-tailed unpaired Student's t-tests. Differences were considered statistically significant at the P , 0.05 level.
General methods. Unless stated otherwise, sample size (n values) are reported as biological replicates of mice and/or SC isolations from separate mice performed on different days. In figure legends where sample size is reported as a range, the exact sample size values are reported below: Fig. 1b : QSCs (n 5 13), CSCs (1.5 DPI, n 5 3; 2.5 DPI, n 5 7; 3.5 DPI, n 5 5), ASCs (1.5 DPI, n 5 3; 2.5 DPI, n 5 5; 3.5 DPI, n 5 5). Fig. 1c : QSCs (n 5 11), CSCs (1 DPI, n 5 2; 1.5 DPI, n 5 2; 2.5 DPI, n 5 2; 3.5 DPI, n 5 2), ASCs (1 DPI, n 5 2; 1.5 DPI, n 5 2; 2.5 DPI, n 5 2; 3.5 DPI, n 5 2). Fig. 2e : QSCs (n 5 4), CSCs (n 5 3), ASCs (n 5 3). Fig. 2f : QSCs (n 5 5), CSCs (n 5 4), ASCs (n 5 3). Fig. 2h : QSCs (n 5 7), CSCs (1 DPI, n 5 3; 2.5 DPI, n 5 3; 3.5 DPI, n 5 4). Fig. 3a : wild-type QSCs (n 5 11), TSC1 KO QSCs (n 5 6). Fig. 3d : wild-type QSCs (n 5 11), WT CSCs (n 5 7), Rptor KO QSCs (n 5 7), Rptor KO CSCs (n 5 6). Fig. 3g : wild-type QSCs (n 5 11), WT CSCs (n 5 7), cMet KO QSCs (n 5 4), cMet KO CSCs (n 5 5). Figure 4e : Normal regeneration (3.5 DPI, n 5 6; 6 DPI, n 5 5; 11 DPI, n 5 3; 15 DPI, n 5 3; 24 DPI, n 5 4), Alert regeneration (3.5 DPI, n 5 5; 6 DPI, n 5 5; 11 DPI, n 5 3; 15 DPI, n 5 3; 24 DPI, n 5 4). Figure 4h : QFAPs (n 5 6), CFAPs (each point, n 5 2), AFAPs (each point, n 5 2). Figure 4i : non-injured (n 5 4), injured (n 5 5). Figure 4j : non-injured 1 PBS (n 5 4), non-injured plus IFN-c (n 5 3), injured plus PBS (n 5 3), injured plus IFN-c (n 5 4).
Extended Data Fig. 1c : non-injured (n 5 2), injured (R-TA, n 5 3; L-TA, n 5 3; R-Quad, n 5 2, triceps, n 5 2). Extended Data Fig. 3i: (n 5 4) , Extended Data Fig. 3j : (n 5 6), Extended Data Fig. 3k: (n 5 3) , Extended Data Fig. 3l: (n 5 5) , Extended Data Fig. 3m : (n 5 6). Extended Data Fig. 5g : wild-type QSCs (n 5 6), wild-type CSCs (n 5 4), cMet KO QSCs (n 5 3), cMet KO CSCs (n 5 6). Extended Data Fig. 6a : non-injured (n 5 6), 2.5 DPI (n 5 3), 7 DPI (n 5 5), 14 DPI (n 5 3), 28 DPI (n 5 3). Extended Data Fig. 6a : QSCs (n 5 13), CSCs (1.5 DPI, n 5 3; 2.5 DPI, n 5 7; 3.5 DPI, n 5 5; 7 DPI, n 5 2; 14 DPI, n 5 3; 21 DPI, n 5 2; 35 DPI, n 5 2), ASCs (1.5 DPI, n 5 3; 2.5 DPI, n 5 5; 3.5 DPI, n 5 5; 7 DPI, n 5 2; 14 DPI, n 5 3; 21 DPI, n 5 2; 35 DPI, n 5 2). Extended Data Fig. 6c : QSCs (n 5 11), CSCs (2.5 DPI, n 5 2; 7 DPI, n 5 2; 14 DPI, n 5 2; 21 DPI, n 5 2; 28 DPI, n 5 2; 35 DPI, n 5 6), ASCs (2.5 DPI, n 5 2; 7 DPI, n 5 2; 14 DPI, n 5 2; 21 DPI, n 5 2; 28 DPI, n 5 2; 35 DPI, n 5 4). Extended Data Fig. 9c : QFAPs (n 5 6), CSCs (each point, n 5 2), ASCs (each point, n 5 2). Extended Data Fig. 9d : non-injured (n 5 4), injured (n 5 5).
In most cases, the data presented were compiled over the course of 2 years, as mice with the appropriate genotype became available. Therefore the magnitude of the effect and variability in the measurements were primary factors in determining sample size and replication of data. Although samples were not explicitly randomized or blinded, mouse identification numbers were used as sample identifiers and thus the genotypes and experimental conditions of each mouse/sample were not readily known or available to the experimenters during sample processing and data collection. The only criteria used to exclude samples involved the health of the animals, such as visible wounds from fighting. In these cases, the animals were handled in accordance with approved IAUCUC guidelines. 
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Extended Data Figure 3 | CSCs have elevated mitochondrial and mTORC1 activity. a, Induction of genes involved in the cell cycle and mitochondrial metabolism in CSCs. Pathway analysis of genes that were induced in CSCs versus QSCs showed enrichment of genes involved in the cell cycle and mitochondrial metabolism. Redundant KEGG pathways that contain overlapping genes were assembled into annotation groups (details of array and enrichment analysis are found in the Methods section). b, CSCs have slightly increased cell volume compared to QSCs. Cell volume was calculated from cell size measurements ( Fig. 2b ) (mean 6 s.e.m., n 5 4 animals, *P , 0.05, **P , 0.01 compared to QSCs). c, CSCs have a slightly greater intracellular ATP concentration than QSCs (mean 6 s.e.m., n 5 4 animals, *P , 0.05 compared to QSCs). d, Increase in photo emission from CSCs expressing luciferase reporter (LuSEAP). Immediately after isolation and plating, bioluminescence imaging of 1 3 10 4 Pax7 CreER/1 ; Rosa26 LuSeAP/1 SCs shows that 2.5 DPI CSCs have greater luminescence than QSCs, ASCs have substantially elevated luminescence. Activated fibro-adipogenic progenitors (AFAPs) were isolated from the same injured muscle as ASCs and plated as a negative control for LuSEAP expression. Light emission from luciferase is dependent on the amounts of luciferase enzyme, ATP and luciferin. Increased ATP and increased expression from the Rosa26 locus in CSCs ( Fig. 2j and Extended Data Fig. 2c ) could both contribute to increased luminescence. Data presented are from a representative experiment with similar results observed in two independent experiments. e, Low magnification image of IF-IHC staining of TA muscle. Boxed areas are of the representative pS6 2 and pS6 1 SCs that are shown in Fig. 2g . f, CSCs have increased levels of pS6 as shown by western blot analysis of whole-cell extracts from 1 3 10 5 cells of each population collected immediately after isolation. g, CSCs show a bimodal distribution of pS6 staining at 1 DPI, with peaks corresponding to the signal in pS6 2 QSCs and pS6 1 ASCs when analysed by FACS (representative FACS plot, similar results observed in 3 independent experiments). h, Sorting SCs for properties of the alert state (that is, high levels of MitoTracker Deep Red (MTDR) staining and YFP expression) enriches for SCs that display the other properties of alert SCs: elevated mTORC1 activity, reduced time to first division and increased propensity to cycle. Representative gating of MTDR Hi ;EYFP Hi SCs (Hi) and MTDR Lo ;EYFP Lo SCs (Lo). i-m, Sorting of Hi SCs reveals a sub-population of QSCs that displays characteristics of the alert state. Hi SC cells have increased mTORC1 activity (i), an increased propensity to cycle in vivo as measured by incorporation of EdU nucleotide 12 h after pulse labelling (j), and an accelerated time to first division (k). Both Hi and Lo SCs stain positive for the SC marker, Pax7 (l). 12 h after an in vivo EdU pulse, most SCs that incorporate nucleotide (quantified in j) stain positive for pS6 (m). Panels i-m are displayed as mean 6 s.e.m., n $ 3 animals, *P , 0.05, **P , 0.01. 
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